0
What DRUG can be used for maintenance of remission in patents with corticosteroid-dependent uc?
Wiki User
∙ 11y agoWant this question answered?
Be notified when an answer is posted
Add your answer:
Earn +20 pts
What has the author Martin A Voet written?
Martin A. Voet has written: 'The generic challenge' -- subject(s): Drug Industry, Drug Legislation, Drugs, Drugs, Generic, Economics, Generic drugs, Generic substitution, Law and legislation, Legislation & jurisprudence, Legislation, Drug, Patent extensions, Patents, Patents as Topic, Pharmaceutical biotechnology
What is Eminem's remission album?
His album is called Recovery. It came out in 2010 and revolves around his recovery from a drug addiction to sleeping pills.
What has the author Donald James Weatherburn written?
Donald James Weatherburn has written: 'Drug law enforcement' -- subject(s): Drug abuse and crime, Drug addicts, Drug control, Heroin abuse, Methadone maintenance, Statistics
Can 6-mercaptopurine be used to treat acute leukemia?
Though 6-mercaptopurine(Mercaptopurine, 6-MP or its brand name Purinethol) is not a preferred drug for acute leukemia, but it is used in combination with other medicines as maintenance treatment of this disease. 6-mercaptopurine can extend the remission of the disease and increase the chances of survival for a patient. See the related link for further information that may be helpful for you.
What has the author David A Fiellin written?
David A. Fiellin has written: 'The Connecticut Methadone Medical Maintenance Pilot Project' -- subject(s): Connecticut Methadone Medical Maintenance Pilot Project, Drug abuse, Methadone maintenance, Treatment
Is the smith food and drug distribution center in Layton Ut hiring in distribution?
Is the smiths food and drug center hiring in the layton distribution center maintenance dept.
Is opium used to stop drug addiction?
No. Various forms of drugs from the opium family can be used to reduce withdrawal symptoms and sometimes for daily maintenance it just depends on the drug that they are addicted to
Does the Food and Drug Administration hold patents on pharmaceuticals?
No, the Food and Drug Administration (FDA) does not hold patents on pharmaceuticals. The FDA is a regulatory agency that approves and monitors the safety and effectiveness of drugs, but it does not have the authority to hold patents. Patents are typically held by pharmaceutical companies or inventors who develop new drugs or therapeutic treatments.
How long before any drug becomes generic?
In the US, drug patents give twenty years of protection, but they are applied for before clinical trials begin, so the effective life of a drug patent tends to be between seven and twelve years.
Is drug addiction a disease?
Yes. There are significant genetic contributions to substance abuse and dependence. However, with the recognition of the affected individual that this is the case, there comes great responsibilities to treat this disease and maintain remission from it, one day at a time.
What do patents protect?
Patents protect inventors from having their work copied by others. The work to be protected must be original, useful, and not obvious. An example of this is the popular drug Zocor. It was under patent until June, 2006, so no other company could make and sell that drug. The patent expired and now other companies can sell the drug labeled with its generic name, Simvastatin. Once issued, a patent can be used to prevent others from making, using, selling or importing any product or service that infringes any valid claim in the issued patent, but only in countries where the patent is issued and valid.
What do patents do?
Patents protect inventors from having their work copied by others. The work to be protected must be original, useful, and not obvious. An example of this is the popular drug Zocor. It was under patent until June, 2006, so no other company could make and sell that drug. The patent expired and now other companies can sell the drug labeled with its generic name, Simvastatin. Once issued, a patent can be used to prevent others from making, using, selling or importing any product or service that infringes any valid claim in the issued patent, but only in countries where the patent is issued and valid.
